| Significant CODM expense categories |
The table below summarized the significant expense categories regularly provided to, and reviewed by, the CODM for the three and six months ended June 30, 2026 and 2025 (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Three Months
Ended June 30, |
|
|
Six Months
Ended June 30, |
|
| |
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical and manufacturing |
|
$ |
1,812 |
|
|
$ |
184 |
|
|
$ |
2,484 |
|
|
$ |
373 |
|
| Other research and development |
|
|
1,028 |
|
|
|
714 |
|
|
|
2,016 |
|
|
|
1,035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total research and development |
|
|
2,840 |
|
|
|
898 |
|
|
|
4,500 |
|
|
|
1,408 |
|
| General and administrative |
|
|
1,610 |
|
|
|
684 |
|
|
|
3,746 |
|
|
|
1,396 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Loss from operations |
|
|
(4,450 |
) |
|
|
(1,582 |
) |
|
|
(8,246 |
) |
|
|
(2,804 |
) |
| Other expense, net |
|
|
52 |
|
|
|
309 |
|
|
|
10 |
|
|
|
796 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Total other expense, net |
|
|
52 |
|
|
|
309 |
|
|
|
10 |
|
|
|
796 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net loss |
|
$ |
(4,502 |
) |
|
$ |
(1,891 |
) |
|
$ |
(8,256 |
) |
|
$ |
(3,600 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The table below summarizes the significant expense categories regularly provided to, and reviewed by, the CODM for the years ended December 31, 2025, 2024 and 2023 (in thousands).
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
Years Ended December 31, |
|
| |
|
2025 |
|
|
2024 |
|
|
2023 |
|
| License and service revenue: |
|
$ |
— |
|
|
$ |
6,359 |
|
|
$ |
— |
|
| Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
| Research and development |
|
|
|
|
|
|
|
|
|
|
|
|
| Clinical and manufacturing |
|
|
718 |
|
|
|
1,193 |
|
|
|
2,577 |
|
| Other research and development |
|
|
2,338 |
|
|
|
2,384 |
|
|
|
6,021 |
|
| Total research and development |
|
|
3,056 |
|
|
|
3,577 |
|
|
|
8,598 |
|
| General and administrative |
|
|
3,382 |
|
|
|
5,250 |
|
|
|
8,690 |
|
| Total operating expenses: |
|
|
6,438 |
|
|
|
8,827 |
|
|
|
17,288 |
|
| Loss from operations |
|
|
(6,438 |
) |
|
|
(2,468 |
) |
|
|
(17,288 |
) |
| Other (income) expense, net |
|
|
(443 |
) |
|
|
675 |
|
|
|
(234 |
) |
| Total other expense (income), net |
|
|
(443 |
) |
|
|
675 |
|
|
|
(234 |
) |
| Net loss |
|
$ |
(5,995 |
) |
|
$ |
(3,143 |
) |
|
$ |
(17,054 |
) |
|